Anuh Pharma Limited (NSE:ANUHPHR)

Market Cap	7.63B -10.3%
Revenue (ttm)	7.76B +17.3%
Net Income	410.46M -13.3%
EPS	4.10 -13.2%
Shares Out	n/a
PE Ratio	18.58
Forward PE	n/a
Dividend	1.50 (1.96%)
Ex-Dividend Date	Aug 14, 2025

Volume	60,326
Average Volume	61,005
Open	78.00
Previous Close	76.17
Day's Range	75.00 - 78.00
52-Week Range	67.00 - 114.90
Beta	0.50
RSI	40.00
Earnings Date	May 20, 2026

About Anuh Pharma

Anuh Pharma Limited engages in the manufacture and sale of bulk drugs and chemicals in India. It offers active pharmaceutical ingredients, including macrolides, anti-TB, anti-bacterial, anti-asthmatics, anti-diabetics, intermediates, expectorant, quinolones, anti-malarial, anti-gout, anti-biotic, anti-platelet, and antihistamines; and corticosteroids, including anti-inflammatory, immunosuppressant, anti-pruritic, anti-mitotic. The company also develops products, such as coagulants, gastrointestinal, anti convulsants, and cholesterol drugs. It a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1960
• Employees: 295
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ANUHPHR

Financial Performance

In fiscal year 2026, Anuh Pharma's revenue was 7.76 billion, an increase of 17.31% compared to the previous year's 6.62 billion. Earnings were 410.46 million, a decrease of -13.32%.